These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8001304)

  • 41. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.
    Sweany AE; Shapiro DR; Tate AC; Goldberg RB; Stein EA
    Clin Ther; 1995; 17(2):186-203. PubMed ID: 7614520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
    Harada N; Kashiwagi A; Nishio Y; Kikkawa R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):111-20. PubMed ID: 10221663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia.
    Strauss WE; Lapsley D; Gaziano JM
    Am Heart J; 1999 Mar; 137(3):458-62. PubMed ID: 10047626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia.
    Wolffenbuttel BH; Mahla G; Muller D; Pentrup A; Black DM
    Neth J Med; 1998 Apr; 52(4):131-7. PubMed ID: 9646621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pravastatin experience in elderly and non-elderly patients.
    Mellies MJ; DeVault AR; Kassler-Taub K; McGovern ME; Pan HY
    Atherosclerosis; 1993 Jun; 101(1):97-110. PubMed ID: 8216507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
    Garg A; Grundy SM
    Ann Intern Med; 1994 Sep; 121(6):416-22. PubMed ID: 8053615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of pravastatin in treatment of hypercholesterolemia in non-insulin-dependent diabetes patients.
    Soonthornpun S; Rattarasarn C; Leelawattana R; Thamprasit A
    J Med Assoc Thai; 1997 Jan; 80(1):9-15. PubMed ID: 9078811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia.
    Davignon J; Roederer G; Montigny M; Hayden MR; Tan MH; Connelly PW; Hegele R; McPherson R; Lupien PJ; Gagné C
    Am J Cardiol; 1994 Feb; 73(5):339-45. PubMed ID: 8109547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A multi-centre study of the efficacy and safety of pravastatin in hypercholesterolaemic patients with non-insulin-dependent diabetes mellitus.
    Inoue Y; Kaku K; Okubo M; Hatao K; Hatao M; Kaneko T; Matsumura S; Ando S; Fujii S
    Curr Med Res Opin; 1994; 13(4):187-94. PubMed ID: 7882697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
    Lewin AJ; Kipnes MS; Meneghini LF; Plotkin DJ; Perevozskaya IT; Shah S; Maccubbin DL; Mitchel YB; Tobert JA;
    Clin Ther; 2004 Mar; 26(3):379-89. PubMed ID: 15110130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy.
    Chan P; Lee CB; Lin TS; Ko JT; Pan WH; Lee YS
    Am J Hypertens; 1995 Nov; 8(11):1099-104. PubMed ID: 8554733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complementary effects of pravastatin and nicotinic acid in the treatment of combined hyperlipidaemia in diabetic and non-diabetic patients.
    Tsalamandris C; Panagiotopoulos S; Sinha A; Cooper ME; Jerums G
    J Cardiovasc Risk; 1994 Oct; 1(3):231-9. PubMed ID: 7621303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a.
    Hunninghake DB; Stein EA; Mellies MJ
    J Clin Pharmacol; 1993 Jun; 33(6):574-80. PubMed ID: 8366183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of primary hypercholesterolemia with pravastatin. A placebo-controlled trial].
    Frederiksen SM; Larsen ML; Oxenbøll IB; Pindborg T; Haghfelt T
    Ugeskr Laeger; 1993 Sep; 155(36):2794-9. PubMed ID: 8236548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-masked comparison of the quality of life of hypercholesterolemic men treated with simvastatin or pravastatin. International Quality of Life Multicenter Group.
    Seed M; Weir MR
    Clin Ther; 1999 Oct; 21(10):1758-70. PubMed ID: 10566571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of low-dose niacin and pravastatin improves the lipid profile in diabetic patients without compromising glycemic control.
    Gardner SF; Marx MA; White LM; Granberry MC; Skelton DR; Fonseca VA
    Ann Pharmacother; 1997 Jun; 31(6):677-82. PubMed ID: 9184704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.
    Tikkanen MJ; Laakso M; Ilmonen M; Helve E; Kaarsalo E; Kilkki E; Saltevo J
    Diabetes Care; 1998 Apr; 21(4):477-81. PubMed ID: 9571327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.